{"transactions":[{"id":2335516,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-14T16:11:30.000Z","date":"2021-12-07","kind":"sale","acquired":false,"shares":37243,"price":0.6832,"value":25444.4176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\"). The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in a single transaction at a price of $0.6832 per share."}],"balance_after":271757,"source":{"system":"sec-edgar","filing":"0001104659-22-033319","document":"tm229111-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000110465922033319/tm229111-1_4seq1.xml","form_type":"4"}},{"id":2590888,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-25T20:32:19.000Z","date":"2021-08-23","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc."}],"balance_after":500000,"derivative":{"exercise_price":1.26,"expiration_date":"2031-08-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-21-109469","document":"tm2125787-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000110465921109469/tm2125787-3_4seq1.xml","form_type":"4"}},{"id":2960885,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2020-12-02T17:26:49.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":465000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: (i) 25% of the options granted under the 2018 Plan will vest after one year of employment with the Company; and (ii) after one year of employment with the Company, 6.25% of the options granted will vest for each additional three (3) months of employment."}],"balance_after":465000,"derivative":{"exercise_price":1.45,"exercise_date":"2021-12-01","expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":465000},"source":{"system":"sec-edgar","filing":"0001104659-20-131634","document":"tm2037478d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000110465920131634/tm2037478d2_4.xml","form_type":"4"}},{"id":2960884,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-02T17:26:49.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":309000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 309,000 shares of iBio, Inc. (the \"Company\") common stock , $0.001 par value per share (the \"Common Stock\") represented by 309,000 restricted stock units (\"RSUs\") granted under the Company's 2018 Omnibus Equity Incentive Plan, as amended (the \"2018 Plan\"). Each RSU represents a contingent right to receive one share of Common Stock. The 309,000 RSUs start vesting pro rata on the (i) first anniversary of the grant date; (ii) second anniversary of the grant date; and (iii) third anniversary of the grant date."}],"balance_after":309000,"source":{"system":"sec-edgar","filing":"0001104659-20-131634","document":"tm2037478d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000110465920131634/tm2037478d2_4.xml","form_type":"4"}},{"id":3074086,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":2140,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These options will vest in three approximately equal annual installments beginning on the one-year anniversary of the date of grant."}],"balance_after":2140,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":2140},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3074085,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":6423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These options vest in full on the one year anniversary of the date of grant."}],"balance_after":6423,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":6423},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3074084,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":4814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options provide for vesting in three approximately equal annual installments beginning on February 28. 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":21.28,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":4814},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3074083,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":4814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options provide for vesting in three approximately equal annual installments beginning on March 9, 2018. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":43.82,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":4814},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3074082,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award vested over three years, and the final one-third vested on June 1, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":30.1,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3074081,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award vested over three years, and the final one-third vested on February 24, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":27.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3074080,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-29T21:37:24.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":5357,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award vested over three years, and the final one-third vested on August 3, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":41.16,"expiration_date":"2026-08-03","underlying":"Common Stock","underlying_shares":5357},"source":{"system":"sec-edgar","filing":"0001019056-20-000439","document":"maddux.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000439/maddux.xml","form_type":"4"}},{"id":3200805,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-19T18:34:33.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":134800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on February 17, 2021."}],"balance_after":134800,"derivative":{"exercise_price":0.498,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":134800},"source":{"system":"sec-edgar","filing":"0001019056-20-000242","document":"maddux_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905620000242/maddux_4.xml","form_type":"4"}},{"id":3380337,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-05T20:54:01.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":122359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on November 1, 2020, the one-year anniversary of the grant date."}],"balance_after":122359,"derivative":{"exercise_price":0.576,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":122359},"source":{"system":"sec-edgar","filing":"0001019056-19-000616","document":"maddux_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905619000616/maddux_4.xml","form_type":"4"}},{"id":3434601,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations, CMO"}}],"security":"Common Stock","published_at":"2019-08-19T08:29:17.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":25000,"price":0.76,"value":19000.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001019056-19-000487","document":"maddux_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905619000487/maddux_4.xml","form_type":"4"}},{"id":3497292,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Operations"}}],"security":"Common Stock","published_at":"2019-06-07T15:18:17.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":20000,"price":0.73,"value":14600.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001593968-19-001343","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000159396819001343/primary_01.xml","form_type":"4"}},{"id":3619427,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-04T21:06:47.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three approximately equal annual installments beginning on February 28, 2020."}],"balance_after":67400,"derivative":{"exercise_price":1.52,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-19-000180","document":"maddux_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905619000180/maddux_4.xml","form_type":"4"}},{"id":3739525,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations"}}],"security":"Common Stock","published_at":"2018-12-07T18:28:31.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":5000,"price":2.37,"value":11850.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001019056-18-001118","document":"white_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905618001118/white_4.xml","form_type":"4"}},{"id":3998483,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2018-03-13T21:39:30.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":67400,"derivative":{"exercise_price":3.13,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-18-000437","document":"maddux_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905618000437/maddux_4.xml","form_type":"4"}},{"id":4138026,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Operations"}}],"security":"Common Stock","published_at":"2017-12-08T18:06:14.000Z","date":"2017-11-15","kind":"purchase","acquired":true,"shares":25000,"price":2.76,"value":69000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001019056-17-000796","document":"maddux_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905617000796/maddux_4.xml","form_type":"4"}},{"id":4298228,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Operations"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-01T21:40:53.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the \"Plan\") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":33700,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000548","document":"maddux_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905617000548/maddux_4.xml","form_type":"4"}},{"id":4421763,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":129149,"kind":"person","name":"Maddux Randy Joe","position":1,"cik":"0001683826","reported_name":"Maddux Randy Joe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Operations"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-27T16:04:51.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments beginning on February 24, 2018."}],"balance_after":108700,"derivative":{"exercise_price":1.96,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000236","document":"maddux_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683826/000101905617000236/maddux_4.xml","form_type":"4"}}]}